– IRELAND, Kingscourt – Kingspan Group plc (LON: KGP), the global leader in high-performance insulation and building envelope solutions, today announced the appointments to its Board of Éimear Moloney as an Independent Non-Executive Director and Paul Murtagh as a Non-Executive Director, effective from 30 April 2021.
About Éimear Moloney
Éimear was previously a senior investment manager in Zurich Life Assurance plc managing asset allocation and various geographic equity portfolios and has excellent knowledge and experience of capital markets and asset management.
She is a fellow of the Institute of Chartered Accountants in Ireland, and a member of the Institute of Directors in Ireland. Éimear also has strong experience in the pharma manufacturing and controls environment as a non-executive Director of Chanelle Pharmaceuticals Group. Éimear is a non-executive Director on the Boards of Hostelworld Group plc where she chairs the Audit Committee and Yew Grove REIT plc.
She has a B.A. Accounting and Finance and MSc. Investment and Treasury from Dublin City University.
About Paul Murtagh
Paul is the Chairman and CEO of Tibidabo Scientific Industries Ltd, and was formerly the Chairman and CEO of Faxitron Bioptics LLC, leading it to its successful sale in 2018. He was also formerly the Chairman of Deerland Probiotics & Enzymes Inc. He has an excellent understanding of the US market and has significant experience in the global build-out of a variety of medical and biotech businesses. Previously he worked in investment banking mergers & acquisitions at Merrill Lynch & Co. in New York and Sydney.
He holds a BComm International from University College Dublin and is a non-executive director of several private companies.
For more information: https://www.kingspan.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
